Guanliang Chen
-
- Diet, Metabolism, and Disease 6
-
- Effects and risks of endocrine disrupting chemicals 3
- Air Quality and Health Impacts 2
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 11
- Adipokines, Inflammation, and Metabolic Diseases 3
- Cervical Cancer and HPV Research 2
- Hepatology top 5%
- Nephrology top 10%
-
- Immune Cell Function and Interaction 4
-
- Adipose Tissue and Metabolism 3
Guanliang Chen
25 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Endocrinology, Diabetes and Metabolism 524
- Health, Toxicology and Mutagenesis 249
- Epidemiology 621
- Hepatology 124
- Nephrology 76
Countries citing papers authored by Guanliang Chen
This map shows the geographic impact of Guanliang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guanliang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guanliang Chen more than expected).
Fields of papers citing papers by Guanliang Chen
This network shows the impact of papers produced by Guanliang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guanliang Chen. The network helps show where Guanliang Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guanliang Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2022 | 2 | |
| 3 | 2022 | 24 | |
| 4 | 2021 | 3 | |
| 5 | 2021 | 56 | |
| 6 | 2021 | 1 | |
| 7 | 2020 | 57 | |
| 8 | 2020 | 34 | |
| 9 | 2020 | 15 | |
| 10 | 2019 | 1 | |
| 11 | 2019 | 29 | |
| 12 | 2019 | 87 | |
| 13 | 2019 | 50 | |
| 14 | SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Micebreakdown → | 2017 | 402 |
| 15 | 2016 | 58 | |
| 16 | 2015 | 59 | |
| 17 | 2015 | 64 | |
| 18 | 2015 | 133 | |
| 19 | 2015 | 26 | |
| 20 | 2014 | 93 |
About Guanliang Chen
Guanliang Chen is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Hepatology, having authored 25 papers that have together received 1.6k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (11 papers), Diet, Metabolism, and Disease (6 papers), Immune Cell Function and Interaction (4 papers), Effects and risks of endocrine disrupting chemicals (3 papers), Adipose Tissue and Metabolism (3 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), Air Quality and Health Impacts (2 papers) and Cervical Cancer and HPV Research (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (524 citations), Health, Toxicology and Mutagenesis (249 citations) and Epidemiology (621 citations). Guanliang Chen has collaborated with scholars based in Japan, China and Germany. Frequent co-authors include Yinhua Ni, Tsuguhito Ota, Hironori Kitade, Naoto Nagata, Liang Xu, Mayumi Nagashimada, Shuichi Kaneko, Fen Zhuge, Zhengwei Fu and Yuanxiang Jin. Their work appears in journals such as Scientific Reports, Chemosphere and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.